ET-1 is known to contribute to osteoblastic progression of prostate cancer cells by stimulating OB proliferation through the negative regulation of the inhibitor of the Wnt signaling, DKK1 which may explain, at least in part, the decrease of DKK1 observed in PC3c cells [35]. This evidence concerns the gene EDN1 and prostate cancer.